| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.26B | 25.54B | 23.38B | 21.61B | 22.27B | 19.12B |
| Gross Profit | 6.27B | 6.24B | 5.11B | 3.82B | 4.72B | 3.33B |
| EBITDA | 5.10B | 5.03B | 3.98B | 3.19B | 4.18B | 3.08B |
| Net Income | 1.91B | 1.55B | 1.93B | 594.95M | 985.25M | 613.59M |
Balance Sheet | ||||||
| Total Assets | 36.06B | 37.04B | 36.89B | 34.30B | 34.74B | 36.02B |
| Cash, Cash Equivalents and Short-Term Investments | 5.23B | 6.51B | 7.08B | 5.50B | 5.55B | 5.39B |
| Total Debt | 100.00M | 2.12B | 1.88B | 2.67B | 3.41B | 6.27B |
| Total Liabilities | 5.13B | 6.07B | 6.76B | 6.44B | 7.38B | 10.28B |
| Stockholders Equity | 30.40B | 30.44B | 29.63B | 27.39B | 26.92B | 25.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.28B | 2.77B | 1.13B | 3.48B | 3.44B |
| Operating Cash Flow | 0.00 | 2.89B | 4.23B | 2.69B | 3.95B | 4.09B |
| Investing Cash Flow | 0.00 | -2.65B | -1.58B | -1.59B | -500.26M | -656.84M |
| Financing Cash Flow | 0.00 | -846.50M | -1.28B | -1.19B | -3.46B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥20.29B | 9.48 | ― | 2.86% | 19.42% | 74.63% | |
75 Outperform | ¥13.69B | 6.74 | ― | 3.90% | -1.72% | 168.62% | |
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥8.11B | 4.65 | ― | 4.24% | -7.88% | -73.98% | |
58 Neutral | ¥5.09B | 2.75 | ― | 4.51% | 0.61% | -453.99% | |
57 Neutral | ¥18.89B | 18.77 | ― | 3.19% | -8.99% | -62.26% |